|
|
||||||||
1 INSERM, Unité 473, 94276 Le Kremlin-Bicêtre Cedex, France
2 Equipe Ecophysiologie, CNRS-UPCM-INSU, Station Biologique, 29682 Roscoff Cedex, France
3 Micromass UK Ltd., Altrincham, Cheshire, WA14 5RZ, United Kingdom
4 Institut de Chimie Moléculaire Paul Sabatier, 31062 Toulouse Cedex 4, France
5 INSERM, Unité 468, Hopital Henri Mondor, 94010 Créteil Cedex, France
Reprint requests to: V. Baudin-Creuza, INSERM U 473, 84 rue du Général Leclerc, 94276 Le Kremlin-Bicêtre, France; e-mail: baudin{at}kb.inserm.fr; fax: ++33-1-49-59-56-61.
(RECEIVED August 21, 2001; FINAL REVISION October 15, 2001; ACCEPTED October 16, 2001)
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1101/ps.35702.
| Abstract |
|---|
|
|
|---|
Cys on the interactions between the human hemoglobin molecules were investigated, and comparisons were made with other variants having an additional cysteine residue. In hemoglobin Porto Alegre (PA), the ß9 mutation induces polymerization by forming interchain disulfide bonds via the extra cysteine. The hemolysate from a heterozygote was separated by gel filtration into a tetrameric fraction and a higher-molecular-weight oligomeric fraction (30%). Reversed-phase high-performance liquid chromatography and electrospray ionization mass spectrometry (ESI-MS) under denaturing conditions showed that the tetrameric fraction contained only normal
- and ß-chains, whereas the oligomeric fraction contained only normal
-chain and disulfide-linked ßPA dimer. Under native conditions, ESI-MS of the oligomeric fraction revealed a principal complex of mass 258,400 Da corresponding to a tetramer of tetramers, and 10% of minor components. Transmission electron microscopy corroborated this structure by showing four spheres of 140 Å diameter surrounding a central cavity. Equilibrium experiments on the oligomer at different concentrations, using gel filtration and dimer exchange experiments with metHbA-CN, showed that the tetramer of tetramers dissociates into smaller species, probably by breaking the dimerdimer allosteric interface. None of the other variants investigated formed such a large oligomer. Keywords: Hemoglobin; disulfide bridge; structure oligomer; oxygen transport
Abbreviations: DTT, dithiothreitol ESI-MS, electrospray ionization mass spectrometry Hb, hemoglobin Hb A, human normal adult hemoglobin Hb PA, hemoglobin Porto Alegre Hb-CN, cyanmethemoglobin Hb-CO, carbonmonoxyhemoglobin DCL-Hb, diaspirin cross-linked hemoglobin RP-HPLC, reversed-phase high-performance liquid chromatography T, Hb tetramer Ti, molecule of i tetramers TEM, transmission electron microscopy TFA, trifluoroacetic acid.
| Introduction |
|---|
|
|
|---|
Cys, carries an extra thiol group oriented towards the exterior of the Hb molecule (Tondo et al. 1963). During storage of the hemolysate, Hb PA spontaneously polymerizes by forming intermolecular disulfide bridges involving this cysteine residue (Tondo 1971). Other substitutions introducing a cysteine residue have been described in human Hb, but only Hb PA, Hb Mississippi ß44(CD3)Ser
Cys (Adams et al. 1987), and Hb Ta-Li ß83(EF7)Gly
Cys (Blackwell et al. 1971) are known to form polymers. Tondo reported that in the fresh hemolysate only tetrameric Hb PA was found. In contrast, polymers were found in the aged hemolysate from homozygous and heterozygous patients (Tondo 1971, 1972). Using ultracentrifugation and osmotic pressure measurements, Tondo found that the polymer from a homozygote was composed of three tetramers of Hb PA, possibly with a closed ring structure (Tondo 1971). Surprisingly, when studying the aged hemolysate from a heterozygote, the same author described a polymer consisting of two Hb tetramers with one abnormal and one normal ß-chain per tetramer (Tondo 1972). Likewise, animal Hbs have been reported that are able to polymerize in vitro such as mouse Hb (BALB/cj) (Bonaventura and Riggs 1967). In all cases, the cysteine residues were in an external position and the polymerization did not appear to alter the functional properties of the Hb.
Here we report on an investigation into the effects of the Cys substitution in Hb PA on the interactions within the oligomer which involve both covalent and noncovalent bonding. We also studied other Hb variants in which the substitution resulted in the introduction of an additional cysteine. Using gel permeation chromatography, electrospray ionization mass spectrometry (ESI-MS) and transmission electron microscopy (TEM), we determined the size and structure of the principal PA oligomer and propose a model for its spatial arrangement.
| Results |
|---|
|
|
|---|
|
- and ß-chains of masses 15,126.4 Da and 15,867.2 Da, respectively. The third component of 31,764.5 Da suggests a dimer composed of two ßPA-chains linked by a disulfide bridge (calculated mass 31,764.6 Da). This substitution was confirmed by further structure analysis. Chromatography of the globin on the Partisil column led to the isolation of an abnormal peak significantly more hydrophobic than the normal ß-chain. RP-HPLC separation of the peptides resulting from aminoethylation, and tryptic digestion of this fraction, showed that the normal ßT-2 peptide was missing and replaced by a large abnormal peak eluting earlier. When this abnormal peptide was analyzed by tandem mass spectrometry (m/z 845.2), it was demonstrated to correspond to a ßT-2 peptide (sequence ß1017) lacking the serine residue (ß9) located at its N-terminus. This situation results from the formation of a new tryptic cleavage site following replacement of Ser ß9 by Cys and aminoethylation.
Purification, size and structure of the oligomers
Gel filtration of the patient's hemolysate (2 mM on a heme basis) revealed the presence of two peaks (Fig. 1
). One peak, amounting to about 70%, eluted at the expected volume for Hb tetramers (molecular weight 64,500 Da). Analysis of this fraction by RP-HPLC yielded only normal
- and ß-chains (Fig. 2A
). When analyzed under denaturing conditions by ESI-MS, this fraction showed only normal
- and ß-chains. The other peak eluted from the gel filtration column over a volume range corresponding to molecular weights ranging from 120 to 350 kD. In the range of loaded volume, we estimated, from the top of the peak, a mean molecular weight of 288 ± 0.5 kD for this species. This value is consistent with a mixture of polymers assembled from four or five tetramers (4.5 ± 0.1). This high-molecular-weight peak showed a shoulder towards lower molecular weights, indicating an equilibrium with smaller species.
|
|
-chain (Fig. 2B
-chains, suggesting that the oligomeric fraction only contains disulfide-linked ßPA dimers (Fig. 2B
-chain and ßPA dimer.
|
8 (ßPA-S-S-PAß)4h16 (257,934 Da) where
is the
-chain (15,126.4 Da), ßPA-S-S-PAß is the dimer of PA chains (31,764.6 Da), and h is the heme group (616.5 Da). Multiply charged series corresponding to minor components (10% of oligomeric Hb) comprising one to three tetramers (T1T3) and five tetramers (T5) were also observed, where T is the tetramer
2 (ßPA-S-S-PAß)h4 of calculated mass 64,483.4 Da.
The study of oligomeric PA by TEM shows that it appears as spheres of 140 Å diameter with a central cavity (Fig. 4
). Some molecules have a crescent shape, suggesting a cleavage between two adjacent subunits (inset in Fig. 4
).
|
2ß2 tetramers (Table 2
ß dimers and the peak width at half height is small, indicating the presence of only one species.
|
|
|
Cys] (Henthorn et al. 1999), and ß° thalassemia showed that this variant Hb was eluted at a volume corresponding to the tetrameric Hb, except for a very small peak displaying an apparent molecular weight of 120 kD (Table 4
Cys] (Adams et al.1987); only a small fraction (3%) of this Hb forms oligomers. The sizes of these oligomers were higher and more heterogenous than those observed for Hb Harrow, the oligomer peak being very wide. Contrary to these two variant Hbs, Hb Ilmenau [ß41(C7)Phe
Cys] (http://globin.cse.psu.edu/cgi-bin/hbvar), Hb Arta [ß45(CD4) Phe
Cys] (Vassilopoulos et al. 1995), Hb Montfermeil [ß130(H8)Tyr
Cys] (http://globin.cse.psu.edu/cgi-bin/hbvar), and Hb Nunobiki [
141(HC3)Arg
Cys] (Shimasaki 1985) did not form polymers; we observed only tetrameric forms by gel filtration.
|
| Discussion |
|---|
|
|
|---|
We report here the study of a hemolysate from a heterozygote for Hb PA. The red cells were stored at -80°C for several months before analysis. Just after thawing and hemolysis, the gel filtration profile showed the presence of tetrameric and oligomeric Hbs. Thus the kinetics of oligomer formation could not be compared to those observed by Tondo, because the preparation and storage conditions were different. In contrast to Tondo's results, both RP-HPLC and ESI-MS analysis show that all the PA ß-chains are involved in the oligomer (30%). The tetrameric Hb fraction (70%) is free of the abnormal subunit. Moreover, the major form of the oligomer has a structure comprising four tetramers of composition [
2 (ßPA-S-S-PAß)h4]4, according to the ESI-MS results under native conditions and TEM analysis. The species of mass 258,400 Da observed by ESI-MS appears to be the most stable form. Its mass is about 0.2% higher than the calculated mass of four tetramers (257,934 Da). This is consistent with measurements that have been made on several invertebrate Hb subunits (200210 kD), where the mass excess ranged between 0.1 and 0.5%. Presumably, the higher than expected mass is due to additional water molecules and alkali metal ions (Green et al. 1999,2001). The ESI-MS results also indicate the presence of an oligomer incorporating a fifth tetramer (T5 in Fig. 3B
); this species is present at a relatively low level probably because of additional constraints.
Several results suggest that the PA oligomer structure is not frozen. First, minor groups of peaks of size T1T3 were observed by ESI-MS, indicating that different structures exist. Second, the filtration studies showed that, when the PA oligomer concentration was greatly decreased, the elution volume increased, indicating a decreased oligomer size. The width of the oligomer peak at half height also increased, indicating a higher heterogeneity of species (Table 2
). Indeed, the minimum peak width occurred when one species was predominant (Dumoulin et al. 1997). The third piece of evidence is that the oligomer interacts with HbA, probably through incorporation of
AßA dimers. These results can be compared to those of Tondo when mixing Hb A and Hb PA tetramers (Tondo and Reishl 1979), even though we did not find any oligomers with ßA subunits in the hemolysate from a heterozygote.
Using ESI-MS and TEM results, we propose the model presented in Figure 6
. The oligomer is composed of four mutated tetramers. In this model, the formation of the fourth S-S bridge with the first tetramer would lead to a closed ring. Our TEM results for the PA oligomer support this hypothetical model. The dimensions of tetrameric hemoglobin are 50 x 55 x 65 Å corresponding to a mean diameter of 57 Å. The calculated diameter of the oligomer central cavity (64 Å) is near to the experimental value (40 Å) measured on electron micrographs (Fig. 4
).
|
To our knowledge, Hb PA is the only variant of human Hb able to assemble into such high-molecular-weight oligomers through covalent bonds. This model is particularly interesting, because the oligomer PA exhibits functional properties similar to those observed for Hb A. In some primitive vertebrates and invertebrates such as annelids, the Hb exhibits deoxygenation-dependent self-association of monomers (Riggs 1998).
The Hb PA oligomer appears to be an interesting model for the realization of a blood substitute. Even at very low concentration, the size of PA remains higher than that observed for Hb A. Nevertheless additional constraints, such as crosslinking, would be needed to avoid separation at the dimerdimer interfaces that do not involve the disulfide bonds.
| Materials and methods |
|---|
|
|
|---|
Hb Ilmenau [ß41(C7)Phe
Cys], Hb Arta [ß45(CD4) Phe
Cys], Hb Harrow [ß118(GH1)Phe
Cys], and Hb Montfermeil [ß130(H8)Tyr
Cys] had been previously studied and were stored at -80°C. Hb Mississippi [ß44(CD3)Ser
Cys] and Hb Nunobiki [
141(HC3)Arg
Cys] were from the reference collection of samples at the Hemoglobin Laboratory of Henri Mondor Hospital (Créteil, France).
Purification of Hb oligomers
The oligomeric and tetrameric fractions were separated by gel filtration of the hemolysate on a SuperoseR 12 HR 10/30 column (Amersham Pharmacia Biotech) equilibrated at 25°C with 150 mM tris-acetate pH 7.5 buffer as described (Manning et al. 1996). The chromatographic fractions were concentrated with 10 kD cutoff microconcentrators (Microcon YM-10, Millipore).
Studies of oligomeric and tetrameric Hbs
The subunit composition of the fractions obtained by gel filtration was determined by RP-HPLC using an Aquapore RP300 column (Brownlee) eluted with a gradient of isopropanol in 0.2% trifluoroacetic acid (TFA) (Wajcman et al. 2001).
Electrospray ionization mass spectrometry (ESI-MS)
Denatured conditions
Aliquots of the fractions isolated by gel filtration were diluted with 50% aqueous acetonitrile containing 0.2% formic acid. These solutions (
2.5 µM based on heme content) were introduced at 5 µL/min into the Z-Spray source of a Quattro Ultima mass spectrometer (Micromass) scanning over m/z 9301180 (8 sec/scan). Data were accumulated for 3 min. Mass scale calibration employed the multiply charged normal
-chain peaks present in each spectrum. The m/z spectra were deconvoluted (m/z 9701180) to present the data on a molecular mass scale using the Maximum Entropy (MaxEnt)-based software supplied with the instrument.
Native conditions
Initially, aliquots of the fractions isolated by gel filtration were diluted with HPLC-grade water. These solutions (200 µL,
5 µM) were then desalted by manually shaking with
10 mg of previously washed (twice with water) mixed bed ion exchange resin beads (AG 501-X8, BioRad) for 1 min. After pipetting the solutions from the beads, ammonium acetate was added to a 10 mM concentration and the pH was adjusted from
6.7 to 7.0 by adding a trace of dilute ammonia solution. These solutions were introduced at 4 µL/min into the Z-Spray source of a time-of-flight instrument (LCT, Micromass). The source temperature was 110°C, and the desolvation gas was turned off. The pressure in the intermediate region between atmospheric pressure and high vacuum was increased to 7.0 mbar (normally
2 mbar) by throttling the backing line to the rotary pump. Data were accumulated over m/z 60016000 for
10 min at several declustering potentials (cone voltages) between 50 and 100 V. Masses of the noncovalently assembled species were determined from smoothed m/z spectra using peak top values by assuming the ions were protonated; i.e., mass = n(m/z-H), where n is the number of charges on an ion and H = 1.00794. Mass scale calibration employed the CS(n+1)In peaks from a separate introduction of CsI (2 mg/mL in 50% aqueous 2-propanol).
Transmission electron microscopy (TEM)
TEM was performed on purified Hb PA prepared as described above. Hb PA was diluted (1:900, final concentration
5 µM on a heme basis) in distilled water, and applied to a very thin carbon substrate supported on a microgrid stained with 2% (w/v) uranyl acetate solution as described by Valentine et al. (1968). The specimens were observed with an electron energy of 80 keV, using a Jeol JEM-1200EX microscope (Jeol).
Kinetics of CO recombination
Kinetics of CO recombination were obtained after flash photolysis using 10-ns YAG laser pulses (Quantel) providing 160 mJ at 532 nm (Marden et al. 1988). Measurements were made at 25°C, 150 mM tris-acetate at pH 7.5, 100 µM CO in 1 mm cuvettes, with observation at 436 nm.
Interaction of Hb PA oligomers with Hb A dimers was tested by mixing Hb PA-CO oligomers and HbA-CN. This method has previously been used to produce and study hybrid Hb tetramers: the two parent forms Hb-CO and HbA-CN can be mixed to produce the dimer-CO*dimer-CN hybrid (Marden et al. 1996). The dimer exchange occurs on the order of 1 sec for liganded Hb. These hybrid molecules show less of the slow (deoxy or T-state) CO rebinding, because only two of the ligands can be photodissociated.
| Acknowledgments |
|---|
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| References |
|---|
|
|
|---|
Cys]: A new variant with anomalous properties. Hemoglobin 11: 435452.[Medline]
Blackwell, R.Q., Liu, C.S., and Wang, C.L. 1971. Hemoglobin Ta-Li: ß83 Gly
Cys. Biochim. Biophys. Acta 243: 467474.[Medline]
Bonaventura, J. and Riggs, A. 1967. Polymerization of hemoglobins of mouse and man: Structural basis. Science 158: 800802.
Dumoulin, A., Manning, L.R., Jenkins, W.T., Winslow, R.M., and Manning, J.M. 1997. Exchange of subunit interfaces between recombinant adult and fetal hemoglobins. Evidence for a functional inter-relationship among regions of the tetramer. J. Biol. Chem. 272: 3132631332.
Green, B.N., Bordoli, R.S., Hanin, L.G., Hallier, F.H., Toulmond, A., and Vinogradov, S.N. 1999. Electrospray ionization mass spectrometric determination of the molecular mass of the
200-kDa globin dodecamer subassemblies in hexagonal bilayer hemoglobins. J. Biol. Chem. 274: 2820628212.
Green, B.N., Gotoh, T., Suzuki, T., Zal, F., Lallier, F.H., Toulmond, A., and Vinogradov, S.N. 2001. Observation of large, non-covalent globin subassemblies in the
3600k Da hexagonal bilayer hemoglobin by electrospray ionization time-of-flight mass spectrometry. J. Mol. Biol. 309: 553560.[CrossRef][Medline]
Henthorn, J.C., Wajcman, H., Promé, D., Riou, J., Kister, J., Baudin-Creuza, V., Davies, S.C., and Galactéros, F. 1999. Hb Harrow [ß118(GH1) Phe
Cys]: A new neutral hemoglobin variant. Hemoglobin 23: 273279.[Medline]
Hocking, D.R. 1997. The separation and identification of hemoglobin variants by isoelectric focusing electrophoresis: An interpretive guide, (ed. T.H.J. Huisman), Isolab Inc. Akron, Ohio.
Manning, L.R., Jenkins, W.T., Hess, J.R., Vandegriff, K., Winslow, R.M., Manning, J.M. 1996. Subunit dissociations in natural and recombinant hemoglobins. Protein Sci. 5: 775781.[Abstract]
Marden, M.C., Kister, J., Bohn, B., and Poyart, C. 1988. T-state hemoglobin with four ligands bound. Biochemistry 27: 16591664.[CrossRef][Medline]
Marden, M.C., Griffon, N., and Poyart, C. 1996. Asymmetric hemoglobin hybrids. J. Mol. Biol. 263: 9097.[CrossRef][Medline]
Martinez, G., Lima, F., Estrada, M., Colombo, B., Heredero, L., and Granda, H. 1977. Hemoglobin Porto Alegre in a Cuban family. J. Med. Genet. 14: 422425.[CrossRef][Medline]
Riggs, A.F. 1998. Self-association, cooperativity and supercooperativity of oxygen binding by hemoglobins. J. Biol. Chem. 201: 10731084.
Sack, J.S., Andrews, L.C., Magnus, K.A., Hanson, J.C., Rubin, J., and Love, W.E. 1978. Location of amino acid residues in human deoxy hemoglobin. Hemoglobin 2: 153169.[Medline]
Schneider, R.G., and Barwick, R.C. 1986. Electrophoretic mobilities of mutant hemoglobins and mutant globin chains. In CRC Handbook Series in Clinical Laboratory Science, Section I, Hematology Vol IV, (eds. R.M. Schmidt, V.F. Fairbanks), pp. 125139. CRC Press, Boca Raton, FL.
Shimasaki, S. 1985. A new hemoglobin variant, hemoglobin Nunobiki [
141(HC3) Arg
Cys]. Notable influence of the carboxy-terminal cysteine upon various physico-chemical characteristics of hemoglobin. J. Clin. Invest. 75: 695701.
Tondo, C.V., Salzano, F.M., and Rucknagel, D.L. 1963. Hemoglobin Porto Alegre, a possible polymer of normal hemoglobin in a Caucasian Brazilian family. Am. J. Hum. Genet. 15: 265279.[Medline]
Tondo, C.V. 1971. Study of the polymerization of hemoglobin Porto Alegre tetramers by disulfide bridge formation. An. Acad. Brasil. Cienc. 43: 651669.
Tondo, C.V. 1972. Hemoglobin Porto Alegre: An assymetric tetramer with only one abnormal ß chain in the aged hemolysate of erythrocytes from the heterozygous carrier (
2AßAßSer
Cys). An. Acad. Brasil. Cienc . 44: 337348.
Tondo, C.V., Bonaventura, J., Bonaventura, C., Brunori, M., Amiconi, G., and Antonini, E. 1974. Functional properties of hemoglobin Porto Alegre (
2ß2Ser
Cys) and the reactivity of its extra cysteinyl residue. Biochim. Biophys. Acta. 342: 1520.[Medline]
Tondo, C.V. and Reishl, E. 1979. Exchange of
-ß dimers of hemoglobin Porto Alegre [ß9(A6) Ser leads to Cys] and normal hemoglobin in the formation of the disulfide polymer. An. Acad. Brasil. Cienc. 51: 757764.[Medline]
Tondo, C.V. 1982. Increased erythrocyte glutathione reductase activity in a hemoglobin Porto Alegre (
2ß2Ser
Cys) carrier. Biochem. Biophys. Res. Commun. 105: 13811388.[CrossRef][Medline]
Valentine, R.G., Shapiro, B.M., and Stadtman, E.R. 1968. Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia Coli. Biochemistry 7: 21432152.[CrossRef][Medline]
Vassilopoulos, G., Papassotiriou, I., Voskaridou, E., Stamoulakatou, A., Premetis, E., Kister, J., Marden, M., Griffon, N., Poyart, C., Wajcman, H., Galactéros, F., and Loukopoulos, D. 1995. Hb Arta [ß45 (CD4) Phe
Cys], a new unstable haemoglobin with reduced oxygen affinity in trans with ß-thalassaemia. Br. J. Haemat. 91: 595601.[Medline]
Wajcman, H., Préhu, C., Bardakdjian-Michau, J., Promé, D., Riou, J., Godart, C., Mathis, M., Hurtrel, D., and Galactéros, F. 2001. Abnormal hemoglobins: Laboratory methods. Hemoglobin 25: 169181.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. Baudin-Creuza, C. Vasseur-Godbillon, C. Pato, C. Prehu, H. Wajcman, and M. C. Marden Transfer of Human {alpha}- to {beta}-Hemoglobin via Its Chaperone Protein: EVIDENCE FOR A NEW STATE J. Biol. Chem., August 27, 2004; 279(35): 36530 - 36533. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Bobofchak, T. Mito, S. J. Texel, A. Bellelli, M. Nemoto, R. J. Traystman, R. C. Koehler, W. S. Brinigar, and C. Fronticelli A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2 transporter Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H549 - H561. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |